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INTRODUCTION
Aortic cross clamping for abdominal aortic surgery may
cause renal dysfunction after surgery. Ischemia-reperfusion
injury is the major mechanism for renal dysfunction during
and following aortic surgery (1). Abdominal aortic cross clamp-
ing induces renal vasoconstriction with a subsequent fall in
renal artery blood flow (RABF) and renal function. Calcium
channel blocker can potentially prevent the vasoconstriction
induced by the effect of endothelin on the renal vascular bed
(2). Magnesium (Mg) serves as a calcium channel blocker in
nature and modulates vascular smooth muscle contraction.
This action is a result of the effect of ionized Mg on the energy-
dependent cation pump (3-5). 
Recently Mg has been explored for a number of potential
indications in anesthetic practice (6-10). The major rationale
for the use of Mg for cardiovascular homeostasis in the anes-
thetic management derives from its ability to inhibit the
release of catecholamines, reducing the sensitivity of  -adren-
ergic receptors to catecholamines, and a direct vasodilator
effect (7, 11). Intravascular administration of Mg causes vasodi-
lation and increases RABF. We hypothesize that Mg might
effectively augment renal perfusion, and prevent renal dys-
function following unclamping of the aorta. The purpose of
our study was to investigate the effect of magnesium sulfate
(MgSO4) on renal perfusion, renal function, and central hemo-
dynamics after supraceliac aortic unclamping in an animal
model.
MATERIALS AND METHODS
This investigation was performed under a protocol approved
by the Institutional Animal Investigation Committee. A total
of 14 mongrels of either sex, weighing 20-25 kg, were entered
into the study. They were divided into two groups, control
group (group C, n=7) and Mg group (group Mg, n=7). Anes-
thesia was induced by 20 mg/kg thiopental sodium and 0.1
mg/kg vecuronium bromide. After tracheal intubation, me-
chanical ventilation (Servo ventilator 900C, Siemens, Sweden)
was done with 50% oxygen with air and 1-1.5% isoflurane
at a tidal volume of 10-15 mL/kg with a respiratory rate of
10-12/min. Tidal volume and respiratory rate were adjusted to
maintain the end-tidal carbon dioxide concentration between
40±5 mmHg (Capnomac, Datex-Ohmeda, Finland). Body
temperature was maintained between 36℃ and 38℃ with
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Effects of Magnesium Sulfate on Supraceliac Aortic Unclamping in
Experimental Dogs
Intravascular administration of magnesium (Mg) causes vasodilation and increases
renal blood flow. The aim of this study was to investigate the renal effect of Mg fol-
lowing unclamping of the supraceliac aorta. Mongrels were divided into two groups,
control (group C, n=7) and Mg group (group Mg, n=7). In group Mg, 30 mg/kg MgSO4
was injected as a bolus immediately prior to unclamping the supraceliac aorta and
thereafter as an infusion (10 mg/kg/hr). The group C received an equivalent volume
of saline solution. Systemic hemodynamics, renal artery blood flow, renal cortical
blood flow (RCBF), renal vascular resistance, and renal function were compared.
Following the aortic unclamping, cardiac output and RCBF were less attenuated,
and the systemic and renal vascular resistance was elevated to a lesser degree in
the group Mg compared to the group C. There was no significant difference in the
plasma renin activity, serum creatinine and Cystatin-C between the two groups. The
present study shows that Mg infusion improves systemic hemodynamics and RCBF
after aortic unclamping. However, we did not observe any improvement in renal func-
tion when Mg was administered after supraceliac aortic unclamping.
Key Words : Aortic Aneurysm; Magnesium; Renal Circulation; Perfusion, Regional; Reperfusion Injury
Received : 12 January 2005
Accepted : 1 April 2005Renal Effect of Magnesium  613
an electric heating pad. Electrocardiogram (lead II) was con-
tinuously monitored.
After inducing anesthesia, left brachial artery was dissect-
ed and a 21-gauge catheter (Angiocatheter, Becton Dickin-
son, Franklin Lakes, NJ, U.S.A.) was placed to monitor blood
pressure continuously and to draw the blood samples. A 5-
French balloon-directed thermal dilution pulmonary artery
catheter (SP510H, Ohmeda, Singapore) was introduced
through the right external jugular vein. The cardiac output
(CO) was measured by thermodilution technique as an aver-
age of three consecutive cold bolus (0℃) injections.
A median laparotomy was performed and supraceliac abdom-
inal aorta was exposed for occlusion and release. A thermal
diffusion microprobe was implanted in the left renal cortex
to measure real-time continuous renal cortical blood flow
(RCBF) simultaneously. For microprobe implantation, the
renal capsule was locally incised and a microprobe was inserted
into the outer renal cortex (depth approximately 15 mm) at
an angle of 45°to the renal surface (12). Minor bleeding after
probe insertion always ceased spontaneously. Renal poles were
not used for implantation. To prevent the microprobe dis-
placement it was fixed to the renal capsule with a 5-0 Prolene
suture. The microprobe was then connected to QFlowTM500
perfusion measurement system (Thermal technologies Inc.,
Cambridge, MA, U.S.A.) to measure RCBF. We identified
the appropriate location of the thermal diffusion microprobe
by k-value. The k-value or tissue conductivity should not
exceed 6.23 m ∙ W/cm/℃ in this system (13). A k-value ex-
ceeding 6.23 m ∙ W/cm/℃ indicates inappropriate micro-
probe positioning or other artifacts. The perfusion results
obtained by perfusion measurement system (measurement
interval 1/sec) were calculated as means of 1 min recordings.
The left renal artery was dissected and an ultrasonic flow
probe (HT107 medical volume flowmeter, Transonic systems
Inc., Ithaca, NY, U.S.A.) was placed around the left renal
artery to measure RABF. Right renal vein was dissected and
24-gauge catheters (Angiocatheter, Becton Dickinson) were
placed to draw the blood samples.
On completion of the surgical preparation, the fluid was con-
tinuously administered with balanced salt solution to achieve
a pulmonary artery wedge pressure (PAWP) of 8-12 mmHg.
Adequate hydration was maintained throughout the experi-
ment with balanced salt solution and colloid in a 3:1 ratio.
After a sufficient stabilization period (30-60 min follow-
ing surgical preparation), blood samples from the right renal
vein for estimation of plasma renin activity were drawn very
slowly to avoid vena cava blood contamination and repeated
at 6 hr after supraceliac aortic unclamping. Mg, calcium, cre-
atinine, and Cystatin-C (a marker of glomerular filtration
rate) concentrations were drawn from the left brachial artery.
At the time of blood sampling, standard hemodynamic vari-
ables, RABF, and RCBF were measured. Renal vascular resis-
tances (RVR) were calculated as following equation, RVR=
[mean arterial pressure (MAP)-central venous pressure (CVP)]
×80/RABF. 
Systemic anticoagulation was achieved with intravenous
100 U/kg heparin sodium 10 min before supraceliac aortic
cross clamping. The exposed supraceliac abdominal aorta was
then occluded with an atraumatic clip for a period of 60 min,
and all data were measured immediately before aortic un-
clamping (baseline). To prevent the catastrophic increase of
blood pressure during the aortic cross clamping, 0.5-5  g/
kg/min sodium nitroprusside (Nitropress Inj, Abott Labora-
tories, North Chicago, IL, U.S.A.), a ultra-short acting vaso-
dilator, was continuously infused and was stopped immedi-
ately before aortic unclamping.
In group Mg, MgSO4 (Magunesin
�, Daewon Pharmaceu-
tical Co., Seoul, Korea), was injected as a bolus 30 mg/kg
over 3 min immediately before aortic unclamping and was
continuously infused 10 mg/kg/hr with a syringe pump (STC
524, Terumo, Tokyo, Japan). The group C received an equiv-
alent volume of saline solution.
Hemodynamic measurements, including heart rate (HR),
MAP, central venous pressure (CVP), pulmonary artery pres-
sure (PAP), PAWP, CO, systemic vascular resistance (SVR),
and pulmonary vascular resistance (PVR), were repeated at
1, 3, and 6 hr after aortic unclamping (Fig. 1). Blood samples
of brachial artery were drawn at 6 hr after aortic unclamping.
SVR and PVR were calculated using standard formula [SVR=
(MAP-CVP)×80/CO and PVR=(PAP-PAWP)×80/CO].
Left kidney was excised and fixed in 10% buffered forma-
lin for histological analysis. The paraffin-embedded speci-
mens were cut perpendicular to the puncture channels in the
segment where the microprobe had been located. After stain-
ing with hematoxylin and eosin microscopic examination
was performed by an independent pathologist for the follow-
ing parameters; insertion channel of microprobe, morphom-
etry of glomerulus, afferent and efferent arterioles, and neu-
trophil infiltration. Upon extraction of the thermal diffusion
microprobes no signs of hemorrhage into the puncture chan-
nel were detected. At the end of each experiment, the animals
were euthanized by anesthesia overdose and intra-arterial injec-
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Fig. 1. Schematic diagram of the experimental protocol and data
collection. RABF, renal artery blood flow; RCBF, renal cortical blood
flow. Biochemistry include plasma renin activity, serum creatinine,
Cystatin-C, and serum magnesium and calcium concentrations. 614 Y. Jang, H.Y. Shin, J.M. Kim, et al.
All data are presented as mean±standard deviation (SD).
Preoperative parameters were compared to those of the cross
clamping and unclamping. Statistical analysis was done by
Mann-Whitney test for difference of hemodynamic parame-
ters among test and control groups. Comparisons of variables
at different times were tested by the Friedman test followed
by Wilcoxon signed-rank test. The five percent level of prob-
ability was accepted as significant. Data was analyzed using
the SPSS statistical package program version 11.0 (SPSS for
Windows, SPSS Inc., Chicago, IL, U.S.A.).
RESULTS
Systemic hemodynamic parameters according to supraceliac
aortic cross clamping and unclamping in the two groups are
presented in Table 1. There were no statistical differences
between the two groups in HR, CVP and PAWP through-
out the experiment. MAP increased after aortic cross clamp-
ing in both groups, but returned to baseline values after un-
clamping. CO was reduced significantly compared to baseline
value at 6 hr after aortic unclamping in group C (p=0.027).
SVR increased at aortic cross clamping in both groups. In
group C, SVR increased significantly in comparison to group
Mg at 6 hr after aortic unclamping (p=0.016). PVR increased
at 3 and 6 hr after aortic unclamping in group C and at 1,
3, and 6 hr after aortic unclamping in group Mg. There were
no statistical differences in PVR between the two groups.
Baseline values of RVR in group C and group Mg were
59.6±14.6 dyn ∙ sec/cm5 and 67.3±24.5 dyn ∙ sec/cm5, res-
pectively (Fig. 2). After aortic cross clamping, the RVR in-
creased in group C and group Mg (p=0.003 and <0.001,
respectively). In group C, the RVR increased compared to
baseline value at 1, 3, and 6 hr after aortic unclamping. In
group Mg, however, the RVR returned to the baseline value
throughout experiment after aortic unclamping. The RABF
decreased in both groups for the duration of the experiment.
There were no statistical differences in RABF between the
two groups. 
Baseline values of RCBF in group C and group Mg were
57.0±11.9 mL/min/100 g and 66.3±24.3 mL/min/100 g,
respectively (Fig. 3). After aortic cross clamping, the RCBF
Fig. 2. Renal vascular resistance, renal artery blood flow, and renal cortical blood flow in anesthetized dogs after supraceliac aortic cross
clamping and unclamping. ACC; supraceliac aortic cross clamping, U-1, 3, and 6=1, 3, and 6 hr after supraceliac aortic unclamping. *p<
0.05 versus baseline, 













































































































































Group C  Group Mg 
Parameters Baseline ACC Unclamp-1 Unclamp-3 Unclamp-6 Group
HR Control 134.7±15.8 126.1±17.7 144.0±10.7 140.7±12.0 144.9±6.5
(bpm) Magnesium 145.3±11.4 124.6±17.2 145.1±11.5 151.6±13.3 150.3±13.2
MAP Control 96.7±12.6 130.7±12.9* 100.1±21.2 100.1±10.6 88.9±8.7
(mmHg) Magnesium 106.1±18.0 127.4±4.3* 102.7±6.9 100.4±12.1 91.1±5.6
CVP Control 8.0±2.4 9.7±1.4 7.0±2.5 7.2±2.1 7.2±2.4
(mmHg) Magnesium 7.2±1.4 8.5±1.6 6.8±1.4 6.7±1.0 6.8±1.8
PAWP Control 9.9±0.7 11.6±2.7 9.6±1.6 9.7±1.1 8.3±1.4 
(mmHg) Magnesium 9.1±1.3 11.1±0.7 9.1±1.3 10.0±2.6 8.9±1.6 
CO Control 3.0±0.9 2.9±0.4 2.5±1.3 2.2±0.9 1.8±0.9*
(L/min) Magnesium 3.0±0.4 2.8±1.2 2.5±0.8 2.5±0.6 2.4±0.9
SVR Control 2521±641 3417±547* 3496±937 4316±1409* 5021±1543*
(dyn ∙ sec/cm
5) Magnesium 2695±784 4001±1668* 3417±1143 3249±913 3197±994
�
PVR Control 239±74 229±38 300±116 371±82* 584±214*
(dyn ∙ sec/cm
5) Magnesium 240±89 253±123 338±109* 363±130* 392±125*
Table 1. Systemic hemodynamic parameters in anesthetized dogs after supraceliac aortic cross clamping and unclamping
Values expressed as mean±SD. *p<0.05 versus baseline, 
�
p<0.05 versus control.
ACC; supraceliac aortic cross clamping, Unclamp-1, 3, and 6=1, 3, and 6 hr after supraceliac aortic unclamping. HR, heart rate; MAP, mean arterial
pressure; CVP, central venous pressure; PAWP, pulmonary atery wedge pressure; CO, cardiac output; SVR, systemic vascular resistance; PVR, pul-
monary vascular resistance.Renal Effect of Magnesium  615
decreased significantly in both groups. At 6 hr after aortic
unclamping, there was a significant difference in RCBF bet-
ween the two groups (p=0.012).
Biochemistry data are presented in Table 2. There were no
significant changes in plasma renin activity, serum creatinine,
and Cystatin-C between the two groups and all values in both
groups were within normal ranges in dogs. Serum Mg con-
centrations increased significantly from 1.66±0.25 to 2.29
±0.24 mg/dL in the group Mg at 6 hr after aortic unclamp-
ing. There was statistically significant difference in serum Mg
concentrations 6 hr after aortic unclamping between the two
groups.
Extraction of probes did not result in any hemorrhage into
the puncture channels. Histologically the glomeruli showed
some neutrophilc and lymphocytic infiltration but the struc-
ture of afferent and efferent arterioles was well preserved in
both groups (Fig. 3).
DISCUSSION
Repair of aortic aneurysm that extend above the level of
the renal arteries is associated with a higher mortality rate
than infrarenal aortic surgery (14). Severe renal microcircu-
latory disturbances during aortic surgery may precede the
perioperative renal function. Although renal dysfunction cer-
tainly increases the mortality after suprarenal aortic aneurys-
mal repair, the ability to alter the course of acute renal failure
associated with aortic surgery is currently limited (15).
To reduce perioperative renal dysfunction, suppressing ren-
ovascular vasoconstriction, renovascular vasodilation, decreas-
ing cellular oxygen consumption, and/or attenuating reper-
fusion injury are crucial (16). Maintenance of adequate renal
perfusion is considered to be the most important strategy
under these circumstances (17). Several adjunctive measures
has been suggested before, during, and after aortic surgery
to prevent postoperative renal dysfunction following aortic
surgery. Commonly used agents like dopamine, mannitol,
and Prostaglandin E1, have not been consistent in preserv-
ing renal function after aortic cross clamping and unclamp-
ing for aneurysm repair (18, 19). According to a previous
study, the vasodilator effect of Mg might also be of use dur-
ing aortic cross clamping for major vascular operations (20),
but in another report intra-aortic Mg during or after aortic
cross clamping had no effect on renal function (21).
MgSO4 has been used as an adjuvant for anesthesia (22),
and has a number of potential indications in anesthetic prac-
tice (6-10). It reduces the requirement for anesthetics and
opioids and potentiates their actions (23). We hypothesized
that MgSO4 administration might augment renal blood flow
and perfusion, and thus prevent the renal dysfunction that
follows aortic cross clamping.
Adequate renal function is a result of a generous renal blood
Fig. 3. Light microscopic findings followed by unclamping of supraceliac aortic cross clamping in dogs. Kidneys were fixed by immersion
in 10% buffered formalin solution. The glomeruli show some neutrophilc and lymphocytic infiltration but the structure of afferent and efferent
arterioles was preserved in both groups (H&E, ×200). (A) group C, (B) group Mg.
A B
Parameters Group Baseline Unclamp-6
Renin activity Control 7.46±1.44 10.24±4.06 
(ng/mL) Magnesium 7.96±1.11 10.64±4.95
Creatinine Control 0.78±0.07 0.84±0.24
(mg/dL) Magnesium 0.84±0.21 0.92±0.24
Cystatin-C Control 0.13±0.01 0.12±0.03
(mg/L) Magnesium 0.13±0.04 0.10±0.02
Magnesium Control 1.51±0.30 1.36±0.29
(mg/dL) Magnesium 1.66±0.25 2.29±0.24*
,�
Calcium Control 0.88±0.04 0.94±0.26 
(mg/dL) Magnesium 0.90±0.04 0.95±0.12
Table 2. Biochemistry parameters according to supraceliac aor-
tic cross clamping and unclamping  
Values expressed as mean±SD. Unclamp-6=6 hr after supraceliac aor-
tic unclamping. 
*p<0.05 versus baseline, 
� p<0.05 versus control. 616 Y. Jang, H.Y. Shin, J.M. Kim, et al.
flow. The actual renal perfusion is driven by intra-renal vascular
resistance. In our present study, the RVR increased through-
out aortic unclamping in group C. However, the RVR rapidly
returned and persisted close to baseline level throughout the
aortic unclamping period in group Mg. This result is coin-
cident with the reports that Mg causes vasodilation in vas-
cular beds and increases renal blood flow (5, 24).
RCBF is a major determinant of renal function. RABF
can be unevenly distributed and shunted from superficial to
deeper cortical vessels in normal physiologic condition and
may be heterogeneous in various pathologic conditions (12,
25). RCBF and medullary blood flow are differentially reg-
ulated by various factors, including vascular structure, inner-
vation density, in sensitivity to norepinephrine, or locally
acting counter-regulatory mechanisms (26). In previous ani-
mal experiment, the renal cortex and medulla had different
responses to drugs, endotoxin, and hypoxic stress (27). There-
fore, a continuous monitoring of RCBF would be of use for
quantification and evaluation of dynamic RCBF changes dur-
ing experimental pharmacological trials, aiming at renal func-
tion improvement (12). The enhanced thermal diffusion elec-
trode which is used in our experimentation is newly devel-
oped and allows continuous quantification of parenchymal
renal perfusion after local probe implantation. In our present
study using thermal diffusion electrode, RCBF decreased at
6 hr after aortic unclamping in group C, whereas the RCBF
returned to baseline value in group Mg. This result may sug-
gest that the administration of MgSO4 prevents the increase
in RVR and improves the RCBF after the aortic unclamping.
However, there were no significant differences between the
groups in the changes in plasma renin activity, creatinine,
and Cystatin-C levels.
Mg is the second most abundant intracellular cation in the
human body. It regulates the movement of calcium into the
smooth muscle cells, and therefore has an important role in
the maintenance of peripheral vascular tone. The adminis-
tration of MgSO4 also has some systemic effects like a rapid
but transient decrease in arterial pressure in hypertensive
patients, but it has no appreciable changes in blood pressure
in normotensive subjects (28). In the present study, the MAP
after aortic unclamping did not change significantly in any
of the groups when compared to baseline. However, the mech-
anism of the maintenance of MAP was different between the
two groups. MgSO4 given as a bolus immediately preceding
aortic unclamping followed by a continuous infusion there-
after significantly attenuated the increase in SVR and the
decrease in CO after aortic unclamping. In group C, however,
the MAP was maintanined by the increase in SVR despite
the decrease in CO after aortic unclamping. These hemody-
namic results demonstrate that the administration of MgSO4
during supraceliac aortic unclamping causes systemically
dilation of vascular bed and attenuates increase in SVR and
decrease in CO following aortic unclamping.
We have several limitations in this present study. At first,
the Mg and saline were administered immediately before
supraceliac aortic unclamping and thereafter as an infusion.
In general, the adjuvants to protect renal dysfunction for
aneurysm repair surgery are administered before aortic cross
clamping or after the induction of anesthesia. Secondly, to
protect renal dysfunction the CO and oxygen delivery should
be well controlled during aortic cross clamping and unclamp-
ing. In our experimental design, however, we did not con-
trol the CO throughout the experimentation. The reason for
this was that we wanted to find out the systemic and renal
effect of Mg itself without control of hemodynamics. Finally,
in spite of the changes in blood flow of the renal cortex and
medulla have different responses, we measured only RCBF
as local renal perfusion but not renal medullary blood flow.
Therefore, the measurement of the renal medullary blood
flow should be simutaneously performed with the RCBF
measurement to understand the whole distribution of the
renal blood flow.
In summary, MgSO4 30 mg/kg over 3 min immediately
before aortic unclamping followed by an infusion of 10 mg/
kg/hr attenuated the increase in RVR and improves RCBF
after aortic unclamping in dogs. And the CO and SVR were
well preserved after aortic unclamping. However, despite
these beneficial effects, we could not find any improvement
of renal function when MgSO4 was administered after supra-
celiac aortic unclamping.
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